Trial Profile
Effect of nelarabine in children, adolescent and young patients with T-cell acute lymphoblastic leukemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2015
Price :
$35
*
At a glance
- Drugs Nelarabine (Primary) ; Cyclophosphamide; Etoposide
- Indications Precursor cell lymphoblastic leukaemia-lymphoma; T-cell leukaemia
- Focus Therapeutic Use
- 10 Apr 2015 New trial record